GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy
GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy
The purpose of this study is to test the ease of using a new device, called the GlowCap that
 reminds the patient to take their breast cancer hormone pill. The study will collect
 information about the experience with this device and what the patient thinks of its role in
 the daily pill taking routine.
Inclusion Criteria:

 -  Early stage breast cancer patients taking adjuvant endocrine therapy (ie, tamoxifen,
 anastrozole, letrozole, exemestane).

 -  Age ≥ 60 years

 -  Must have broadband internet access at home (to enable the base for the system to
 communicate to the Vitality server).

 -  Must have a landline or mobile phone

 Exclusion Criteria:

 -  Non-English speaking patients